Published September 1, 2025
| Version v1
Journal article
Open
GEC-ESTRO guidelines for commissioning and quality assurance of TG-43 based brachytherapy treatment planning systems.
Authors/Creators
Authors/Creators
- 1. Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium
- 2. Département de Physique, Université Laval, Québec, Canada
- 3. Centre Antoine-Lacassagne, Nice, France
- 4. Calvary Mater Newcastle, Newcastle, Australia
- 5. Department of Medical Physics, Clatterbridge Cancer Centre, Liverpool, United Kingdom
- 6. Imperial College Healthcare NHS Trust, London, United Kingdom
- 7. Department of Radiation Oncology, Alpert Medical School of Brown University, Providence, RI, USA
- 8. Radiotherapy Department, La Fe Hospital, Valencia, Spain
- 9. Department of Radiation Oncology, The Alfred Hospital, Melbourne, Australia
- 10. Catharina Hospital Eindhoven, Eindhoven, the Netherlands
- 11. University Hospital Augsburg, Augsburg, Germany
- 12. Northern Ireland Cancer Centre, Belfast, United Kingdom
- 13. University Hospital Galway, Galway, Ireland
- 14. Clinic of Radiotherapy, UKSH, Campus Kiel, Kiel, Germany
Description
This report defines practical guidelines for (a) commissioning a TG-43-based treatment planning system for brachytherapy, and (b) establishing a continuous quality assurance program for the TPS. The main functionalities of the TPS are described, including image import and geometry, source specification, dose calculation, applicator specification and treatment plan data output, and recommended tests are given. For all tests, the frequency and tolerance are summarized in tables. For the different imaging modalities detailed descriptions of the necessary phantoms are provided in the supplementary data. These guidelines aim to help physicists to setup a comprehensive quality management program for BT TPSs.
Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved.
Notes
Mauro Carrara (National Cancer Institute, Milan, Italy), Yury Niatsetski (Elekta, The Netherlands), Stavroula Giannouli (Varian, USA), and Michael Andr\u00E1ssy (BEBIG, Germany) are gratefully acknowledged for their contributions and review of this report. We thank the following ESTRO reviewers for their thorough evaluation of this report: Georgina Fr\u00F6hlich (National Institute of Oncology, Budapest, Hungary), Christian Kirisits (Medical University of Vienna, Austria), Margaret Bidmead (Royal Marsden Hospital, London, UK).